Komori
Taki Chemical (4025) · TargetRaised

Upward revision to the full-year earnings forecast for the fiscal year ending December 2026

First written in 2026-08-06. 1 of 1 entries say "Raised", first in 2026-08-06. Latest entry: 2026-08-06.

1entries
1years
1from disclosures
Share on X
How it moved
Same theme, other companies

This thread is not in a theme yet. When the same subject shows up in other companies' filings, you can compare them here.

Full recordFilings, disclosures and news, newest first
  1. 2026-08-06RaisedRevision of earnings forecasts

    「For details, please see the separately disclosed notice issued today (6 August 2026), titled "Notice Concerning Upward Revision to Earnings Forecasts and Revision to Dividend Forecast (Increase in Dividend)."」

    Based on interim results, the full-year earnings forecast for the fiscal year ending December 2026 was revised to net sales of ¥45.3 billion, operating income of ¥3.45 billion, ordinary income of ¥4.1 billion and net income attributable to owners of the parent of ¥3.5 billion.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Taki Chemical yet. It last moved in the Revision of earnings forecasts of 2026-08-06: "Raised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Upward revision to the full-year earnings forecast for the fiscal year ending December 2026 | TAKI CHEMICAL CO.,LTD. (4025) | Komori